A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

WITHDRAWN

UPMC Hillman Cancer Center, Pittsburgh

RECRUITING

Georgetown Lombardi Cancer Center, Washington D.C.

RECRUITING

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore

RECRUITING

Virginia Cancer Specialists Research Institute, Fairfax

RECRUITING

Universtity of Virginia Health System, Charlottesville

RECRUITING

Oncology & Hematology Associates of Southwest Virginia, Blacksburg

RECRUITING

Medical University of South Carolina Hollings Cancer Center, Charleston

RECRUITING

The Oncology Institute of Hope and Innovation, Fort Lauderdale

RECRUITING

Moffitt Cancer Center, Tampa

RECRUITING

Southern Cancer Center, Daphne

RECRUITING

SCRI Oncology Partners, Nashville

RECRUITING

Zangmeister Cancer Center, Columbus

RECRUITING

University Hospital - Cleveland Medical Center, Cleveland

ACTIVE_NOT_RECRUITING

Cleveland Clinic, Cleveland

RECRUITING

Oncology Hematology Care Clinical Trials, Cincinnati

RECRUITING

Henry Ford Hospital, Detroit

RECRUITING

Marshfield Medical Center, Marshfield

RECRUITING

Minnesota Oncology Hematology, Burnsville

RECRUITING

Illinois Cancer Specialists, Niles

RECRUITING

Clermont Oncology Center, Clermont

RECRUITING

Nebraska Cancer Specialists, Grand Island

RECRUITING

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas

RECRUITING

University of Texas Southwestern Medical Center, Dallas

RECRUITING

Rocky Mountain Cancer Centers, Lone Tree

RECRUITING

The Oncology Institute of Hope and Innovation, Long Beach

RECRUITING

Oncology Associates of Oregon, Eugene

RECRUITING

Northwest Cancer Specialists, Vancouver

RECRUITING

Beth Israel Deaconess Medical Center, Boston

RECRUITING

Dana Farber Cancer Institute, Boston